Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study1

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 51.e1-51.e7

  Lee, Wen Yuan ^a,b,c   Sun, Li Min ^d   Lin, Cheng Li ^a,e   Liang, Ji An ^a,b,c   Chang, Yen Jung ^d   Sung, Fung Chang ^a   Kao, Chia Hung ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; Cohort study; Prostate cancer; Spinal cord injury

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SPINAL CORD INJURY; TAIWAN;

BLADDER CANCER; COHORT STUDY; PROSTATE CANCER; SPINAL CORD INJURY;

AGED; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SPINAL CORD INJURIES; TAIWAN; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84890802573     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.07.019     Document Type: Article

References (33)

1. Sekhon L.H., Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001, 26:S2-S12.
2. van den Berg M.E., Castellote J.M., Mahillo-Fernandez I., de Pedro-Cuesta J. Incidence of spinal cord injury worldwide: a systematic review. Neuroepidemiology 2010, 34:184-192.
3. McDonald J.W., Sadowsky C. Spinal-cord injury. Lancet 2002, 359:417-425.
4. Wu J.C., Chen Y.C., Liu L., et al. Effects of age, gender, and socio-economic status on the incidence of spinal cord injury: an assessment using the eleven-year comprehensive nationwide database of Taiwan. J Neurotrauma 2012, 29:889-897.
5. Strauss D.J., Devivo M.J., Paculdo D.R., Shavelle R.M. Trends in life expectancy after spinal cord injury. Arch Phys Med Rehabil 2006, 87:1079-1085.
6. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592.
7. Cancer Statistics Annual Report. Taiwan Cancer Registry, 〈〉 2012 [accessed 12.9.12]. http://tcr.cph.ntu.edu.tw/main.php?Page=N2.
8. Patel N., Ngo K., Hastings J., Ketchum N., Sepahpanah F. Prevalence of prostate cancer in patients with chronic spinal cord injury. PM R 2011, 3:633-636.
9. Bartoletti R., Gavazzi A., Cai T., et al. Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. Eur Urol 2009, 56:142-148.
10. Shim H.B., Jung T.Y., Lee J.K., Ku J.H. Prostate activity and prostate cancer in spinal cord injury. Prostate Cancer Prostatic Dis 2006, 9:115-120.
11. Frisbie J.H. Cancer of the prostate in myelopathy patients: lower risk with higher level of paralysis. J Spinal Cord Med 2001, 24:92-95.
12. Pramudji C.K., Mutchnik S.E., DeConcini D., Boone T.B. Prostate cancer screening with PSA in spinal cord injured men. J Urol 2002, 167:1303-1305.
13. Kalisvaart J.F., Katsumi H.K., Ronningen L.D., Hovey R.M. Bladder cancer in spinal cord injury patients. Spinal Cord 2010, 48:257-261.
14. Groah S.L., Weitzenkamp D.A., Lammertse D.P., et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 2002, 83:346-351.
15. Bejany D.E., Lockhart J.L., Rhamy R.K. Malignant vesical tumors following spinal cord injury. J Urol 1987, 138:1390-1392.
16. Kaufman J.M., Fam B., Jacobs S.C., et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977, 118:967-971.
17. Cheng TM. Taiwan's National Health Insurance system: high value for the dollar. In Okma, K.G.H. and Crivelli, L. ed. Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. New Jersey: World Scientific, 2009, pp.71-204.
18. Huang T.S., Wang Y.H., Chiang H.S., Lien Y.N. Pituitary testicular and pituitary-thyroid axes in spinal cord-injured males. Metabolism 1993, 42:516-521.
19. Kim H.T. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007, 13:559-565.
20. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
21. Kohler B.A., Ward E., McCarthy B.J., et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011, 103:714-736.
22. Schulman C.C., Irani J., Morote J., et al. Testosterone measurements in patients with prostate cancer. Eur Urol 2010, 58:65-74.
23. Clark M.J., Schopp L.H., Mazurek M.O., et al. Testosterone levels among men with spinal cord injury: relationship between time since injury and laboratory values. Am J Phys Med Rehabil 2008, 87:758-767.
24. Lynne C.M., Aballa T.C., Wang T.J., et al. Serum and semen prostate specific antigen concentrations are different in young spinal cord injured men compared to normal controls. J Urol 1999, 162:89-91.
25. McVary K.T., Razzaq A., Lee C., et al. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 1994, 51:99-107.
26. Wang J.M., McKenna K.E., McVary K.T., Lee C. Requirement of innervations for maintenance of structural and functional integrity in the rat prostate. Biol Reprod 1991, 44:1171-1176.
27. Pannek J., Berges R.R., Cubick G., Meindl R., Senge T. Prostate size and PSA serum levels in male patients with spinal cord injury. Urology 2003, 62:845-848.
28. Durga A., Sepahpanah F., Regozzi M., Hastings J., Crane D.A. Prevalence of testosterone deficiency after spinal cord injury. PM R 2011, 3:929-932.
29. Scott P.A., Perkash I., Mode D., Wolfe V.A., Terris M.K. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients. Urology 2004, 63:509-512.
30. Frisbie J.H., Binard J. Low prevalence of prostatic cancer among myelopathy patients. J Am Paraplegia Soc 1994, 17:148-149.
31. Subramonian K., Cartwright R.A., Harnden P., Harrison S.C. Bladder cancer in patients with spinal cord injuries. BJU Int 2004, 93:739-743.
32. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?. Urology 2002, 59:240-244.
33. West D.A., Cummings J.M., Longo W.E., et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology 1999, 53:292-297.